Handattu, S. P., Datta, G., Epand, R. M., Epand, R. F., Palgunachari, M. N., Mishra, V. K., . . . Garber, D. W. (2010). Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null mice. The American Society for Biochemistry and Molecular Biology.
Chicago Style CitationHandattu, Shaila P., et al. Oral Administration of L-mR18L, a Single Domain Cationic Amphipathic Helical Peptide, Inhibits Lesion Formation in ApoE Null Mice. The American Society for Biochemistry and Molecular Biology, 2010.
Cita MLAHandattu, Shaila P., et al. Oral Administration of L-mR18L, a Single Domain Cationic Amphipathic Helical Peptide, Inhibits Lesion Formation in ApoE Null Mice. The American Society for Biochemistry and Molecular Biology, 2010.